Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Feb;23(2):381–382. doi: 10.1128/jcm.23.2.381-382.1986

Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test.

D L Jungkind, S A DiRenzo, S J Young
PMCID: PMC268649  PMID: 3009536

Abstract

The Abbott enzyme immunoassay (Abbott Laboratories, North Chicago, Ill.) for human T-cell lymphotropic virus type III (HTLV-III) antibody was evaluated to determine the effect of using heat-inactivated (56 degrees C for 30 min) serum as the sample. Each of 58 nonreactive serum samples gave a higher A492 value when tested after heat inactivation. Ten of the samples became reactive after heating. Heat-inactivated serum should not be used in the current Abbott HTLV-III antibody test, because this can cause false-positive results.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curran J. W., Lawrence D. N., Jaffe H., Kaplan J. E., Zyla L. D., Chamberland M., Weinstein R., Lui K. J., Schonberger L. B., Spira T. J. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med. 1984 Jan 12;310(2):69–75. doi: 10.1056/NEJM198401123100201. [DOI] [PubMed] [Google Scholar]
  2. Federico J. V., Gershon R. R. AIDS--safety practices for clinical and research laboratories. Infect Control. 1984 Apr;5(4):185–187. doi: 10.1017/s0195941700059191. [DOI] [PubMed] [Google Scholar]
  3. Hardy A. M., Allen J. R., Morgan W. M., Curran J. W. The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA. 1985 Jan 11;253(2):215–220. [PubMed] [Google Scholar]
  4. Hirsch M. S., Wormser G. P., Schooley R. T., Ho D. D., Felsenstein D., Hopkins C. C., Joline C., Duncanson F., Sarngadharan M. G., Saxinger C. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med. 1985 Jan 3;312(1):1–4. doi: 10.1056/NEJM198501033120101. [DOI] [PubMed] [Google Scholar]
  5. McDougal J. S., Martin L. S., Cort S. P., Mozen M., Heldebrant C. M., Evatt B. L. Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest. 1985 Aug;76(2):875–877. doi: 10.1172/JCI112045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Redfield R. R., Markham P. D., Salahuddin S. Z., Sarngadharan M. G., Bodner A. J., Folks T. M., Ballou W. R., Wright D. C., Gallo R. C. Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. JAMA. 1985 Mar 15;253(11):1571–1573. [PubMed] [Google Scholar]
  7. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  8. Weiss S. H., Goedert J. J., Sarngadharan M. G., Bodner A. J., Gallo R. C., Blattner W. A. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA. 1985 Jan 11;253(2):221–225. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES